Diagnostic and Interventional Cardiology

Two-Year Data from International COVID-19 STEMI Research Reveals Mortality is Decreasing for COVID-19 Patients with Heart Attacks but Remains High for Unvaccinated Patients

April 12, 2022 – The Minneapolis Heart Institute Foundation (MHIF) has announced the first presentation and simultaneous ...

April 12, 2022

News | Atrial Fibrillation

Zio by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

April 12, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...

April 12, 2022

The American College of Cardiology has issued an expert consensus decision pathway for the evaluation and management of adults with key cardiovascular consequences of COVID-19.

News | Coronavirus (COVID-19)

ACC Issues Clinical Guidance on Cardiovascular Consequences of COVID-19

April 12, 2022 — The American College of Cardiology has issued an expert consensus decision pathway for the evaluation ...

April 12, 2022

Sponsored Content

Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation.

Feature | Atrial Fibrillation

Increasing Early Detection of Atrial Fibrillation Through Improved Short-Term Monitoring

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

December 07, 2021

Fitbit received clearance from the U.S. Food and Drug Administration for our new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib). The algorithm will power our new Irregular Heart Rhythm Notifications feature on Fitbit.

News | Wearables

New Fitbit Feature Makes AFib Detection More Accessible

April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG ...

April 12, 2022

Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute at Cedars-Sinai and the Mark S. Siegel Family Foundation Distinguished Professor

News | Heart Failure

Cell-Derived Therapy May Help Repair Abnormal Heart Rhythm

April 12, 2022 — Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm ...

April 12, 2022

Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include coronary use.

News | Guidewires

FDA Clears Four New Coronary Micro Support Catheters

April 12, 2022 — Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include ...

April 12, 2022

Sponsored Content

Cardiovascular Ultrasound Analytics Aids Re-accreditation Process

Feature | Analytics Software

The Benefits of Data Analytics in Clinical Reporting

Accurate reporting is essential to producing the reliable analytics needed to meet lab accreditation standards. This is ...

October 27, 2021

Radiation to the heart during treatment for locally advanced lung cancer is associated with an increased risk of major adverse cardiac events within the first two years following treatment. The higher the cardiac dose exposure, the higher the risk of a cardiac event.

News | Cardiac Imaging

Simple Changes in Care Reduced Heart Exposure During Lung Cancer Radiation Treatment

April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an ...

April 11, 2022

Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after seeing a patient, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

News | Heart Failure

Electronic Alert Improves Guideline Adherence for Heart Failure Treatment

April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they ...

April 08, 2022

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

News | Heart Failure

Patiromer Helps Patients Stay on Optimal Heart Failure Therapy

April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...

April 08, 2022

Sponsored Content

Feature | Cardiovascular Information Systems (CVIS)

Improving Consistency and Standardization With Structured Reporting

Jeff Rieder M.D., a cardiologist with Coastal Cardiology Charleston, clearly recalls the time when reporting was ...

July 26, 2021

Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.

News | Structural Heart

Rate of Structural Valve Deterioration Lower with TAVR than with SAVR

April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less ...

April 08, 2022

The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.

News | STEMI

ACC Program sees Improvement in Global Heart Attack Care

April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing ...

April 07, 2022

News | Cardiovascular Clinical Studies

SLN360 Markedly Reduces Lipoprotein(a), an Important Cause of Heart Disease

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

April 06, 2022

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Mining Cardiology Data to Optimize Patient Care and Improve Productivity

During the COVID-19 pandemic, many cardiology departments were faced with the daunting task of supporting inpatient and ...

June 18, 2021

Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery.

News | Hypertension

Blood Pressure Management Strategy During Surgery Has No Impact on Major Cardiovascular Complications

April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...

April 07, 2022

News | Cardiovascular Clinical Studies

Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

April 07, 2022

News | Structural Heart

No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...

April 07, 2022